524 related articles for article (PubMed ID: 24649933)
1. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
[TBL] [Abstract][Full Text] [Related]
2. IMM-H004, A New Coumarin Derivative, Improved Focal Cerebral Ischemia via Blood-Brain Barrier Protection in Rats.
Niu F; Song XY; Hu JF; Zuo W; Kong LL; Wang XF; Han N; Chen NH
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2065-2073. PubMed ID: 28669655
[TBL] [Abstract][Full Text] [Related]
3. IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation.
Ai QD; Chen C; Chu S; Zhang Z; Luo Y; Guan F; Lin M; Liu D; Wang S; Chen N
Transl Res; 2019 Oct; 212():36-53. PubMed ID: 31176667
[TBL] [Abstract][Full Text] [Related]
4. Salidroside improves brain ischemic injury by activating PI3K/Akt pathway and reduces complications induced by delayed tPA treatment.
Zuo W; Yan F; Zhang B; Hu X; Mei D
Eur J Pharmacol; 2018 Jul; 830():128-138. PubMed ID: 29626425
[TBL] [Abstract][Full Text] [Related]
5. Compound IMM-H004, a novel coumarin derivative, protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia.
Zuo W; Zhang W; Han N; Chen NH
CNS Neurosci Ther; 2015 Mar; 21(3):280-8. PubMed ID: 25601434
[TBL] [Abstract][Full Text] [Related]
6. IMM-H004, a novel courmarin derivative, protects against oxygen-and glucose-deprivation/restoration-induced apoptosis in PC12 cells.
Ji HJ; Wang DM; Hu JF; Sun MN; Li G; Li ZP; Wu DH; Liu G; Chen NH
Eur J Pharmacol; 2014 Jan; 723():259-66. PubMed ID: 24291097
[TBL] [Abstract][Full Text] [Related]
7. IMM-H004 Protects against Cerebral Ischemia Injury and Cardiopulmonary Complications via CKLF1 Mediated Inflammation Pathway in Adult and Aged Rats.
Ai Q; Chen C; Chu S; Luo Y; Zhang Z; Zhang S; Yang P; Gao Y; Zhang X; Chen N
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987181
[TBL] [Abstract][Full Text] [Related]
8. IMM-H004, a Novel Coumarin Derivative Compound, Inhibits H
Song XY; Hu JF; Wu DH; Ji HJ; Chen NH
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3396-3403. PubMed ID: 30243729
[TBL] [Abstract][Full Text] [Related]
9. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
[TBL] [Abstract][Full Text] [Related]
10. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA.
Yi JS; Kim YH; Koh JY
Exp Neurol; 2004 Oct; 189(2):354-60. PubMed ID: 15380485
[TBL] [Abstract][Full Text] [Related]
11. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
12. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.
Li Q; Han X; Lan X; Hong X; Li Q; Gao Y; Luo T; Yang Q; Koehler RC; Zhai Y; Zhou J; Wang J
Neurobiol Dis; 2017 Dec; 108():173-182. PubMed ID: 28830843
[TBL] [Abstract][Full Text] [Related]
14. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
15. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.
Tan Z; Lucke-Wold BP; Logsdon AF; Turner RC; Tan C; Li X; Hongpaison J; Alkon DL; Simpkins JW; Rosen CL; Huber JD
Eur J Pharmacol; 2015 Oct; 764():404-412. PubMed ID: 26189021
[TBL] [Abstract][Full Text] [Related]
16. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
17. The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat.
Zhang L; Zhang ZG; Liu XS; Hozeska-Solgot A; Chopp M
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2470-5. PubMed ID: 17717296
[TBL] [Abstract][Full Text] [Related]
18. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
19. Effects of a TAFI-inhibitor combined with a suboptimal dose of rtPA in a murine thromboembolic model of stroke.
Durand A; Chauveau F; Cho TH; Kallus C; Wagner M; Boutitie F; Maucort-Boulch D; Berthezène Y; Wiart M; Nighoghossian N
Cerebrovasc Dis; 2014; 38(4):268-75. PubMed ID: 25401979
[TBL] [Abstract][Full Text] [Related]
20. Upregulating the Expression of Survivin-HBXIP Complex Contributes to the Protective Role of IMM-H004 in Transient Global Cerebral Ischemia/Reperfusion.
Chu SF; Zhang Z; Zhang W; Zhang MJ; Gao Y; Han N; Zuo W; Huang HY; Chen NH
Mol Neurobiol; 2017 Jan; 54(1):524-540. PubMed ID: 26742528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
